Evidence map›Paper›PMID 40445479›Full record

Trial reportNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

Intermittent theta burst stimulation improves spasticity, pain and cognitive functions in progressive multiple sclerosis: a pilot study.

Rezzan Yildiz, Mehmet Ilker Yon, Tahir Kurtulus Yoldas, Evren Yasar, Elif Yalcin Topcuoglu, Funda Eren

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rezzan YildizAvcilar Murat Koluk State Hospital, İstanbul, Turkey. rezzanyildiz@gmail.com.ORCID http://orcid.org/0000-0002-7656-2048
Mehmet Ilker YonAnkara Bilkent City Hospital, Ankara Yildirim Beyazit University Medical School, Neurology Clinic, Ankara, Turkey.ORCID http://orcid.org/0000-0002-5031-6607
Tahir Kurtulus YoldasAnkara Bilkent City Hospital, Ankara Yildirim Beyazit University Medical School, Neurology Clinic, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4950-9142
Evren YasarPhysical Therapy and Rehabilitation Clinic, Yozgat Bozok University Medical School, Yozgat, Turkey.ORCID http://orcid.org/0000-0002-1019-7148
Elif Yalcin TopcuogluPhysical Therapy and Rehabilitation Clinic, Ankara Bilkent City Hospital, Ankara, Turkey.ORCID http://orcid.org/0009-0003-4345-9241
Funda ErenAnkara Bilkent City Hospital, Medical Biochemistry, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8649-2493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMultiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system marked by inflammation and demyelination. Neurofilament light chain (NfL) serves as a biomarker for neurodegeneration. Non-invasive brain stimulation techniques such as transcranial magnetic stimulation (TMS) may alleviate MS-related symptoms.

objectiveTo assess the effects of intermittent theta burst stimulation (i-TBS), a TMS protocol, on spasticity, disability, quality of life, fatigue, cognition, and serum NfL levels in patients with progressive MS.

methodsThirty-six patients with primary or secondary progressive MS were randomized to either i-TBS (10 sessions over 2 weeks) or control (no stimulation). Outcomes included EDSS, MAS, VAS, walking speed, MSQOL-54, fatigue, cognition, and serum NfL. Assessments were conducted at baseline and 3 months (both groups), and also at 1 month in the i-TBS group.

resultsi-TBS significantly improved spasticity (p = 0.002), pain (p = 0.002), walking speed (p = 0.001), and daily activities (p = 0.005). Improvements were also observed in verbal learning (p = 0.020) and visuospatial memory (p = 0.006). No significant change in serum NfL levels was detected.

conclusionAlthough i-TBS did not alter serum NfL levels, it was associated with symptom relief and cognitive gains in progressive MS. These preliminary results support the potential of i-TBS as a supportive neurorehabilitation strategy.

Indexed as

Multiple Sclerosis, Chronic ProgressiveMuscle SpasticityPainTranscranial Magnetic StimulationAdultCognitionFemaleHumansMaleMiddle AgedNeurofilament ProteinsPilot ProjectsQuality of LifeTreatment Outcomeneurofilament protein LNeurofilament Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.